Introduction
============

Hypertension as a global health threat can increase the risk of cardiovascular diseases (CVD). Many lifestyle and metabolic risk factors can result in elevated blood pressure (BP) and hypertension, among which the association between hypertension and obesity is always highlighted ([@ref-17]; [@ref-1]; [@ref-19]). Anthropometric obesity indices including body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and neck circumference (NC) have been widely used to examine the obesity status, and studies from various populations have revealed the association between hypertension and these indices ([@ref-37]; [@ref-26]; [@ref-18]; [@ref-34]; [@ref-6]).

In addition to above generally used indices, wrist circumference (WrC) emerged as a novel anthropometric index in recent years, which is an easily obtained measure in estimating the body frame and regional fat distribution ([@ref-25]; [@ref-22]; [@ref-16]; [@ref-35]). Published findings showed that WrC was positively associated with several CVD risk factors, especially among adolescent populations ([@ref-36]; [@ref-11]; [@ref-13]), while findings from adults are inconsistent ([@ref-9]; [@ref-30]; [@ref-12]; [@ref-5]). Additionally, no study showed if WrC was stronger associated with BP or hypertension compared to other anthropometric obesity indices.

The prevalence of hypertension in China is very high and has regional differences, with higher rate among northeastern Chinese residents than whom living in the south part ([@ref-33]; [@ref-31]). Although previous studies have shown generally used obesity indices (eg., BMI, WC, et al.,) was positively associated with hypertension in the specific populations, the association of WrC with BP and hypertension remained unknown. Therefore, in this study we are aiming to: (1) estimate the association of WrC with BP; and (2) compare the strength of this association to the other generally used anthropometric obesity indices among northeastern Chinese community-dwelling residents.

![Flow chart for the present study.](peerj-07-7599-g001){#fig-1}

Materials & Methods
===================

Study design and participants
-----------------------------

This is a cross-sectional study based on urban community-dwelling residents in Shenhe district, Shenyang City, Liaoning Province, China. Details of the methods of enrollment have been reported previously ([@ref-6]; [@ref-32]). In brief, in the first stage, all 14 blocks of Shenhe district were selected and eight residential communities were randomly selected from each of the blocks. In the second stage, systematic sampling was conducted to select 25 households in each residential community. In the third stage, within each household, residents older than 18 years old who lived in the district for at least 2 years were randomly selected without replacement. Finally, 2,761 local residents were recruited to finish the questionnaires and accepted the relevant physical examinations and biochemical tests. Among 2,761 participants, those who did not meet the inclusion criteria in this study were excluded as following: 74 participants missing either information of weight, height, WC, hip circumference, NC or WrC; 2 participants younger than 20 years old; and 354 participants who used to be diagnosed as either cancer or CVD ([Fig. 1](#fig-1){ref-type="fig"}). As a result, 2,331 participants (761 male and 1,570 female participants) were remained for final analyses. Since all participants were randomly selected from communities without the consideration of gender, the total numbers of males and females were different.

To confirm the sample size involved in final analysis is enough or not, we calculate the minimum sample size required according to the following formula: $\documentclass[12pt]{minimal}
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}{}$n={Z}_{1-\alpha /2}^{2}\times p(1-p)/{d}^{2}$\end{document}$ ([@ref-3]). In this formula, *Z*~1−*α*∕2~ is standard normal variate (at 5% type I error (*P*-value \<0.05), *Z*~1−*α*∕2~ is 1.96), *p* is the expected proportion in population based on previous studies, and d is the absolute error or precision (we decided *d* as 0.05 in our study). As a previous survey from northern Chinese population showed, the prevalence of hypertension was 48.9% and 30.8% in male and female participants, respectively ([@ref-29]). Therefore, the calculated minimum sample size for the current study were as following: *n* (male) = 1.96^2^ × 0.489 (1--0.489)/0.05^2^ = 384; *n* (female) = 1.96^2^ × 0.308 (1--0.308)/0.05^2^ = 328. The final sample size we selected for analysis was large enough compared to the number we calculated.

This study was in accordance with the World Medical Association Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects and was approved by the Ethics Committee of China Medical University (No: CMU62073024; July 15th, 2008). A written informed consent form was obtained from each participant after they were informed of the objectives and benefits of this study.

Obesity indices
---------------

In this study, body weight, height and other circumferences were all measured twice using a vertical weight scale and a metric scale with standardized protocols, and to the nearest 0.1 kilogram (kg) and 0.1 centimeter (cm), respectively. All participants were asked to accept measuring of body weight and height wearing light clothes without shoes. BMI was then calculated as weight (kg) divided by the square of the height (m). WC was measured at the level of the midpoint between the lower rib margin and the iliac crest, and hip circumference was measured at the level of maximal protrusion of the gluteal muscles. WHR was calculated as WC (cm) divided by the hip circumference (cm). WHtR was calculated as WC (cm) divided by height (cm). NC was measured at the level of the laryngeal prominence while participants were asked to be in the standing position with the head held erect and eyes facing forward. WrC was measured when participants were asked to hold their arm on a flat surface, and the superior border of the tape measure was placed just distal to the prominences of radial and ulnar bones.

Measuring of BP and the definition of hypertension
--------------------------------------------------

BP was measured using a standard mercury-column sphygmomanometer after 15 min of rest in the sitting position based on the standardized procedural guideline ([@ref-15]). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were determined by the first and the fifth Korotkoff sounds. We measured BP on both right and left arm firstly, and the arm with higher blood pressure would be selected to obtain three consecutive measurements with a time interval of at least two minutes ([@ref-27]). Then, the average on the selected arm would be recorded as the final BP. Before measuring, participants were also need to be asked for not doing following behaviors, including drinking alcohol, tea or coffee, smoking, or taking any exercise for at least 30 min before measuring BP. In this study, hypertension was defined as systolic blood pressure (SBP)/diastolic blood pressure (DBP) ≥140/90 mmHg or anti-hypertensive medication use ([@ref-27]).

Other risk factor measurements
------------------------------

All participants were asked for permission to collect a blood sample after an overnight fast of longer than 8 h. The concentrations of total cholesterol (TC), triglycerides (TG), high density lipid cholesterol (HDL-C), and fasting glucose were examined using Mindray Autoanalyzer (BS 380 type; Mindray Ltd.; Shenzhen, China) in local community health service centers. All assays were performed according to the manufacturer's instructions. In addition, self-administered questionnaires were also used to obtain information on demographic characteristics, medical history, medication use, smoking habits, and other pertinent factors. Trained staff members confirmed the reported information with each participant. In this study, smoking status was categorized as current smokers (smoking during the last one year or quit smoking for less than six months), past smokers (quit smoking for more than six months), and never. Drinking status were categorized as current drinkers (at least twice per week for male and once per week for female), past drinkers (quit drinking for more than six months), and never.

Statistical analysis
--------------------

We have tested distributions of all continuous variables using Shapiro--Wilk test, and found that all these variables followed normal distributions (*p*-value \>0.05). Therefore, we showed values of all continuous variables in mean and standard deviation (SD). Categorical variables were presented as percentages. Student t test and chi-square test were respectively used to estimate the difference of continuous and categorical variables between male and female. Six obesity indices were estimated in this study as following: BMI, WC, WHR, WHtR, NC and WrC. All six anthropometric obesity indices were standardized by being divided by their SD, respectively, so that crude and adjusted slopes per SD increase of each obesity index could be compared with each other. Multivariable linear regression models were used to estimate the crude and adjusted associations of BP (SBP and DBP) with per SD increase of each obesity index among participants without any anti-hypertensive medication use. Odds ratio (OR) and 95% confidence interval (95%CI) were used to estimate the risk of hypertension per SD increase of each obesity index using multivariable logistic regression models. In this study, we used three models in above-mentioned linear and logistic regressions: Model 1 (unadjusted), Model 2 (adjusted for age and gender), Model 3 (adjusted for smoking, alcohol drinking, fasting glucose, TG, TC and HDL-C in addition to Model 2). The ability of predicting hypertension using each obesity index together with other risk factors (confounders in Model 3) was examined by receiver operative characteristic (ROC) curves. We thereafter compared areas under ROC curves (AUC) of other 5 obesity indices to that of the index whose OR was largest in multivariable logistic regression model. The Bonferroni adjustment for multiple comparisons was used to adjust *p*-values. The subgroup analysis for gender was also performed, and *p*-values of interactions by gender on associations of obesity indices with BP and hypertension were estimated. All statistical analyses were performed by SAS 9.4 software (SAS Institute, Inc., Cary, North Carolina), and *p*-value \<0.05 was considered as statistical significance.

Results
=======

Baseline characteristics
------------------------

Baseline characteristics of 2,331 participants are showed in the [Table 1](#table-1){ref-type="table"}. As it is shown, male participants were generally older than female participants. Except WHtR, the other five obesity indices (i.e., BMI, WC, WHR, NC, WrC) in male subjects were larger than that in female subjects (*P*-values were 0.293 for WHtR, and \<0.001 for other five indices). Also, male participants showed higher levels of SBP and DBP than female participants (*p*-values were \<0.001). The prevalence of hypertension among male participants (42.4%) was also found higher than that in females (35.5%) (*P*-value was 0.001). Additionally, male participants showed dramatically higher rates of current smokers (24.3%) and drinkers (51.5%) (*p*-values were \<0.001).
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###### Characteristics of Participants from Shenhe District, Liaoning Province, China (2,331 participants, aged 20 to 94 years old, examined in 2015).

![](peerj-07-7599-g004)

                                    Male participants (*n* = 761)                    Female participants (*n* = 1,570)   *P*-value
  --------------------------------- ------------------------------------------------ ----------------------------------- -----------
  Age (years old)                   58.9 ± 11.2[^\*^](#table-1fn3){ref-type="fn"}    57.7 ± 11.6                         0.013
  Weight (kg)                       73.3 ± 10.8[^\*^](#table-1fn3){ref-type="fn"}    62.0 ± 9.0                          \<0.001
  Height (cm)                       172.1 ± 5.1[^\*^](#table-1fn3){ref-type="fn"}    160.2 ± 4.7                         \<0.001
  BMI (kg/m^2^)                     24.7 ± 3.4[^\*^](#table-1fn3){ref-type="fn"}     24.2 ± 3.3                          \<0.001
  WC (cm)                           89.4 ± 9.0[^\*^](#table-1fn3){ref-type="fn"}     82.8 ± 8.3                          \<0.001
  WHtR                              0.5 ± 0.1                                        0.5 ± 0.1                           0.293
  Hip circumference (cm)            99.7 ± 8.8[^\*^](#table-1fn3){ref-type="fn"}     95.8 ± 8.7                          \<0.001
  WHR                               0.9 ± 0.1[^\*^](#table-1fn3){ref-type="fn"}      0.9 ± 0.1                           \<0.001
  NC (cm)                           37.5 ± 4.6[^\*^](#table-1fn3){ref-type="fn"}     34.4 ± 5.1                          \<0.001
  WrC (cm)                          19.2 ± 4.4[^\*^](#table-1fn3){ref-type="fn"}     17.0 ± 4.0                          \<0.001
  SBP (mmHg)                        131.9 ± 12.1[^\*^](#table-1fn3){ref-type="fn"}   127.4 ± 14.5                        \<0.001
  DBP (mmHg)                        81.5 ± 8.3[^\*^](#table-1fn3){ref-type="fn"}     78.0 ± 8.5                          \<0.001
  Fasting glucose (mmol/L)          5.9 ± 1.8                                        5.7 ± 2.8                           0.103
  TG (mmol/L)                       2.2 ± 6.4                                        1.8 ± 1.1                           0.066
  TC (mmol/L)                       5.0 ± 1.0[^\*^](#table-1fn3){ref-type="fn"}      5.3 ± 1.2                           \<0.001
  HDL-C (mmol/L)                    1.4 ± 0.4[^\*^](#table-1fn3){ref-type="fn"}      1.5 ± 0.5                           \<0.001
  Hypertension (%)                  42.4[^\*^](#table-1fn3){ref-type="fn"}           35.5                                0.001
  Antihypertensive medication (%)   27.5[^\*^](#table-1fn3){ref-type="fn"}           23.1                                0.020
  Smoking (%)                                                                                                            \<0.001
  Current                           24.3[^\*^](#table-1fn3){ref-type="fn"}           1.5                                 
  Past                              16.0                                             2.0                                 
  Never                             59.7                                             96.5                                
  Drinking (%)                                                                                                           \<0.001
  Current                           51.5[^\*^](#table-1fn3){ref-type="fn"}           14.3                                
  Past                              2.6                                              0.8                                 
  Never                             45.9                                             84.9                                

**Notes.**

Values are presented as mean ± SD, or %.

AbbreviationsBMIbody mass indexWCwaist circumferenceWHRwaist-to-hip ratioWHtRwaist-to-height ratioNCneck circumferenceWrCwrist circumferenceSBPsystolic blood pressureDBPdiastolic blood pressureTGtriglyceridesTCtotal cholesterolHDL-Chigh density lipid cholesterol

*p* \< 0.05, statistically significant.

10.7717/peerj.7599/table-2

###### Crude and adjusted associations of blood pressure with per standard deviation increase of obesity indices (1,760 participants without anti-hypertensive medication, aged 20 to 94 years old, examined in 2015).

![](peerj-07-7599-g005)

            Model 1                                  Model 2      Model 3                                                                                                                          
  --------- ---------------------------------------- ------------ --------- ---------------------------------------- ------------ --------- ---------------------------------------- ------------- ---------
  **SBP**                                                                                                                                                                                          
  BMI       2.73[^\*^](#table-2fn3){ref-type="fn"}   2.13, 3.33   \<0.001   2.52[^\*^](#table-2fn3){ref-type="fn"}   1.96, 3.08   \<0.001   2.45[^\*^](#table-2fn3){ref-type="fn"}   1.89, 3.02    \<0.001
  WC        3.22[^\*^](#table-2fn3){ref-type="fn"}   2.64, 3.80   \<0.001   2.49[^\*^](#table-2fn3){ref-type="fn"}   1.89, 3.08   \<0.001   2.39[^\*^](#table-2fn3){ref-type="fn"}   1.79, 3.00    \<0.001
  WHR       1.73[^\*^](#table-2fn3){ref-type="fn"}   1.14, 2.32   \<0.001   1.12[^\*^](#table-2fn3){ref-type="fn"}   0.55, 1.69   \<0.001   1.13[^\*^](#table-2fn3){ref-type="fn"}   0.55, 1.71    \<0.001
  WHtR      2.72[^\*^](#table-2fn3){ref-type="fn"}   2.16, 3.29   \<0.001   2.10[^\*^](#table-2fn3){ref-type="fn"}   1.56, 2.64   \<0.001   2.01[^\*^](#table-2fn3){ref-type="fn"}   1.47, 2.55    \<0.001
  NC        2.53[^\*^](#table-2fn3){ref-type="fn"}   1.89, 3.16   \<0.001   1.49[^\*^](#table-2fn3){ref-type="fn"}   0.85, 2.12   \<0.001   1.35[^\*^](#table-2fn3){ref-type="fn"}   0.71, 2.00    \<0.001
  WrC       1.40[^\*^](#table-2fn3){ref-type="fn"}   0.76, 2.03   \<0.001   0.64[^\*^](#table-2fn3){ref-type="fn"}   0.02, 1.25   0.043     0.59                                     −0.03, 1.20   0.062
  **DBP**                                                                                                                                                                                          
  BMI       1.73[^\*^](#table-2fn3){ref-type="fn"}   1.36, 2.10   \<0.001   1.59[^\*^](#table-2fn3){ref-type="fn"}   1.23, 1.95   \<0.001   1.53[^\*^](#table-2fn3){ref-type="fn"}   1.17, 1.89    \<0.001
  WC        1.81[^\*^](#table-2fn3){ref-type="fn"}   1.44, 2.17   \<0.001   1.33[^\*^](#table-2fn3){ref-type="fn"}   0.94, 1.71   \<0.001   1.23[^\*^](#table-2fn3){ref-type="fn"}   0.84, 1.61    \<0.001
  WHR       0.80[^\*^](#table-2fn3){ref-type="fn"}   0.43, 1.17   \<0.001   0.41[^\*^](#table-2fn3){ref-type="fn"}   0.04, 0.78   0.031     0.41[^\*^](#table-2fn3){ref-type="fn"}   0.04, 0.78    0.031
  WHtR      1.36[^\*^](#table-2fn3){ref-type="fn"}   1.00, 1.71   \<0.001   1.10[^\*^](#table-2fn3){ref-type="fn"}   0.75, 1.45   \<0.001   1.02[^\*^](#table-2fn3){ref-type="fn"}   0.68, 1.37    \<0.001
  NC        1.46[^\*^](#table-2fn3){ref-type="fn"}   1.07, 1.86   \<0.001   0.88[^\*^](#table-2fn3){ref-type="fn"}   0.48, 1.29   \<0.001   0.68[^\*^](#table-2fn3){ref-type="fn"}   0.27, 1.09    0.001
  WrC       0.95[^\*^](#table-2fn3){ref-type="fn"}   0.56, 1.35   \<0.001   0.51[^\*^](#table-2fn3){ref-type="fn"}   0.12, 0.91   0.011     0.49[^\*^](#table-2fn3){ref-type="fn"}   0.10, 0.88    0.014

**Notes.**

Model 1: unadjusted; Model 2: adjusted for age and gender; Model 3: adjusted for smoking, alcohol drinking, fasting glucose, TG, TC, and HDL-C in addition to Model 2.

AbbreviationsBPblood pressureSBPsystolic blood pressureDBPdiastolic blood pressureBMIbody mass indexWCwaist circumferenceWHRwaist-to-hip ratioWHtRwaist-to-height ratioNCneck circumferenceWrCwrist circumference

*p* \< 0.05, statistically significant.

The associations of WrC and the other obesity indices with BP
-------------------------------------------------------------

[Table 2](#table-2){ref-type="table"} shows the crude (Model 1) and adjusted (Model 2, 3) associations of SBP and DBP with per SD increase of each obesity indices. In the Model 1, WrC and other 5 obesity indices were all found positively associated with both SBP and DBP (*p*-values were \<0.001). These positive associations remained present in the Model 2, which further adjusted for age and gender (*p*-values of associations of SBP with obesity indices were 0.043 for WrC, and \<0.001 for other five indices; *p*-values of associations of DBP with obesity indices were 0.011 for WrC, 0.031 for WHR, and \<0.001 for other four indices). However, in the Model 3, the association between WrC and SBP was not statistically significant (*P*-value was 0.062). In contrast, the other five obesity indices remained the positive associations with both SBP and DBP (*p*-values of association of SBP with five obesity indices but WrC were \<0.001; *p*-values of associations of DBP with obesity indices were 0.031 for WHR, and \<0.001 for other four indices but NC, whose *P*-value was 0.001). Furthermore, comparison of the increases of BP per SD of each obesity indices showed that BMI was the largest, with 2.52 mmHg for SBP and 1.59 mmHg for DBP in Model 2 and 2.45 mmHg for SBP and 1.53 mmHg for DBP in Model 3. In gender stratified analyses, no associations of WrC with SBP and DBP were found in either male or female participants after adjustment for all risk factors ([Fig. 2](#fig-2){ref-type="fig"}) (*p*-values for SBP were 0.068 and 0.336 in male and female; *p*-values for DBP were 0.117 and 0.090 in male and female). On the contrary, the positive associations of BMI, WC and WHtR with SBP and DBP were found, respectively in both male and female participants even after consideration of all risk factors ([Fig. 2](#fig-2){ref-type="fig"}) (*p*-values of association of SBP with BMI were \<0.001 in both male and female; *p*-values of association of SBP with WC were 0.006 and \<0.001 in male and female; *p*-values of association of SBP with WHtR were 0.012 and \<0.001 in male and female; *p*-values of association of DBP with BMI were \<0.001 in both male and female; *p*-values of association of DBP with WC were 0.005 and \<0.001 in male and female; *p*-values of association of DBP with WHtR were 0.010 and \<0.001 in male and female). Besides, we also found stronger associations of both WC and WHtR with SBP in female than that in male (*p*-values for interactions by gender were 0.014 and 0.031 for WC and WHtR, respectively) ([Fig. 2A](#fig-2){ref-type="fig"}).

![Association of systolic blood pressure (A) and diastolic blood pressure (B) with obesity indices classified by gender (1,760 participants without anti-hypertensive medication, examined in 2015).\
The linear regression model was adjusted for age, smoking, alcohol drinking, fasting glucose, TG, TC, and HDL-C (male participants, *n* = 552; female participants, *n* = 1, 208) **Abbreviations:** BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; NC, neck circumference; WrC, wrist circumference.](peerj-07-7599-g002){#fig-2}

The associations of WrC and the other obesity indices with hypertension
-----------------------------------------------------------------------

The associations of the prevalence of hypertension and obesity indices are shown in the [Table 3](#table-3){ref-type="table"}. The findings suggested positive associations of five obesity indices but WHR with hypertension even after adjustments for all risk factors in Model 3 (*P*-values were 0.024 for WrC, 0.064 for WHR and \<0.001 for other four indices). However, OR values of WrC kept the smallest (OR was 1.16, 95 CI% \[1.07--1.27\] in Model 1; OR was 1.11, 95 CI% \[1.02--1.21\] in Model 2; and OR was 1.11, 95 CI% \[1.01--1.21\] in Model 3, respectively) compared with the other five indices. The association of BMI with hypertension was strongest after adjustments for risk factors (OR was 1.59, 95 CI% \[1.44--1.75\] in Model 2; and OR was 1.57, 95 CI% \[1.42--1.73\] in Model 3). Gender stratified analyses showed that WrC was only associated with hypertension in male after adjustment for all risk factors (*P*-value was 0.035), while no interaction by gender was found ([Fig. 3](#fig-3){ref-type="fig"}) (*P*-value for interaction was 0.252). In contrast, BMI, WC and WHtR were found positively associated with hypertension in both male and female participants after adjusting for all risk factors ([Fig. 3](#fig-3){ref-type="fig"}) (*P*-values for BMI were \<0.001 in both male and female; *p*-values for WC were 0.019 and \<0.001 in male and female; *p*-values for WHtR were 0.019 and \<0.001 in male and female). Additionally, the associations of WC and WHtR with hypertension in female were found strongly higher than that in male (*p*-values for interaction by gender were 0.004 and 0.019 for WC and WHtR, respectively) ([Fig. 3](#fig-3){ref-type="fig"}).

10.7717/peerj.7599/table-3

###### Crude and adjusted Associations of hypertension with per standard deviation increase of obesity indices (2,331 participants, aged 20 to 94 years old, examined in 2015).

![](peerj-07-7599-g006)

         Model 1                                  Model 2      Model 3                                                                                                                         
  ------ ---------------------------------------- ------------ --------- ---------------------------------------- ------------ --------- ---------------------------------------- ------------ ---------
  BMI    1.53[^\*^](#table-3fn3){ref-type="fn"}   1.40, 1.68   \<0.001   1.59[^\*^](#table-3fn3){ref-type="fn"}   1.44, 1.75   \<0.001   1.57[^\*^](#table-3fn3){ref-type="fn"}   1.42, 1.73   \<0.001
  WC     1.54[^\*^](#table-3fn3){ref-type="fn"}   1.41, 1.68   \<0.001   1.52[^\*^](#table-3fn3){ref-type="fn"}   1.38, 1.68   \<0.001   1.49[^\*^](#table-3fn3){ref-type="fn"}   1.35, 1.65   \<0.001
  WHR    1.16[^\*^](#table-3fn3){ref-type="fn"}   1.06, 1.26   \<0.001   1.11[^\*^](#table-3fn3){ref-type="fn"}   1.01, 1.22   0.029     1.09                                     1.00, 1.20   0.064
  WHtR   1.50[^\*^](#table-3fn3){ref-type="fn"}   1.38, 1.63   \<0.001   1.44[^\*^](#table-3fn3){ref-type="fn"}   1.32, 1.57   \<0.001   1.41[^\*^](#table-3fn3){ref-type="fn"}   1.29, 1.54   \<0.001
  NC     1.34[^\*^](#table-3fn3){ref-type="fn"}   1.21, 1.48   \<0.001   1.25[^\*^](#table-3fn3){ref-type="fn"}   1.12, 1.39   \<0.001   1.25[^\*^](#table-3fn3){ref-type="fn"}   1.12, 1.40   \<0.001
  WrC    1.16[^\*^](#table-3fn3){ref-type="fn"}   1.07, 1.27   \<0.001   1.11[^\*^](#table-3fn3){ref-type="fn"}   1.02, 1.21   0.023     1.11[^\*^](#table-3fn3){ref-type="fn"}   1.01, 1.21   0.024

**Notes.**

Model 1: unadjusted; Model 2: adjusted for age and gender; Model 3: adjusted for smoking, alcohol drinking, fasting glucose, TG, TC, and HDL-C in addition to Model 2.

AbbreviationsORodds ratioBMIbody mass indexWCwaist circumferenceWHRwaist-to-hip ratioWHtRwaist-to-height ratioNCneck circumferenceWrCwrist circumference

*p* \< 0.05, statistically significant.

![Association of hypertension with per standard deviation of obesity indices classified by gender (2,331 participants aged 20 to 94 years old, examined in 2015).\
The logistic regression model was adjusted for age, smoking, alcohol drinking, fasting glucose, TG, TC, and HDL-C (male participants, *n* = 761; female participants, *n* = 1,570) **Abbreviations:** OR, odds ratio; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; NC, neck circumference; WrC, wrist circumference.](peerj-07-7599-g003){#fig-3}

Furthermore, we compared the AUC of each obesity indices in predicting hypertension under the control of risk factors. As [Table 4](#table-4){ref-type="table"} shows, the AUC of BMI was the largest (0.709) among the 6 obesity indices. Compared to BMI, the AUC of WHR (AUC = 0.674), NC (AUC = 0.681) and WrC (AUC = 0.674) were found significantly lower (adjusted *p*-values were \<0.001). Similar results were also suggested in female participants ([Table 4](#table-4){ref-type="table"}).

10.7717/peerj.7599/table-4

###### Areas under receiver operating characteristic curves for predicting hypertension by obesity indices and other factors (2,331 participants, aged 20 to 94 years old, examined in 2015).

AUC of all five obesity indices except BMI were compared with that of BMI; other factors include age, gender, smoking, alcohol drinking, fasting glucose, TG, TC, and HDL-C; *p*-values were adjusted using Bonferroni adjusment.

![](peerj-07-7599-g007)

                                      AUC                                       95%CI          *P*-value   Adjusted *p*-value
  ----------------------------------- ----------------------------------------- -------------- ----------- --------------------
  BMI+other factors                   0.709                                     0.680, 0.730   ref.        ref.
  WC + other factors                  0.699                                     0.677, 0.720   0.101       1.000
  WHR + other factors                 0.674[^\*^](#table-4fn2){ref-type="fn"}   0.653, 0.696   \<0.001     \<0.001
  WHtR + other factors                0.697                                     0.675, 0.718   0.045       0.675
  NC + other factors                  0.681[^\*^](#table-4fn2){ref-type="fn"}   0.659, 0.718   \<0.001     \<0.001
  WrC + other factors                 0.674[^\*^](#table-4fn2){ref-type="fn"}   0.652, 0.695   \<0.001     \<0.001
  Male Participants (*n* = 761)                                                                            
  BMI + other factors                 0.671                                     0.633, 0.709   ref.        ref.
  WC + other factors                  0.639                                     0.600, 0.678   0.006       0.090
  WHR + other factors                 0.634                                     0.595, 0.673   0.004       0.060
  WHtR + other factors                0.638                                     0.599, 0.677   0.004       0.060
  NC + other factors                  0.646                                     0.607, 0.685   0.072       1.000
  WrC + other factors                 0.643                                     0.604, 0.682   0.039       0.585
  Female Participants (*n* = 1,570)                                                                        
  BMI + other factors                 0.726                                     0.701, 0.761   ref.        ref.
  WC + other factors                  0.728                                     0.702, 0.753   0.746       1.000
  WHR + other factors                 0.699[^\*^](#table-4fn2){ref-type="fn"}   0.673, 0.725   \<0.001     \<0.001
  WHtR + other factors                0.725                                     0.699, 0.750   0.870       1.000
  NC + other factors                  0.702[^\*^](#table-4fn2){ref-type="fn"}   0.676, 0.728   \<0.001     0.006
  WrC + other factors                 0.697[^\*^](#table-4fn2){ref-type="fn"}   0.671, 0.724   \<0.001     \<0.001

**Notes.**

AbbreviationsAUCarea under curveBMIbody mass indexWCwaist circumferenceWHRwaist-to-hip ratioWHtRwaist-to-height ratioNCneck circumferenceWrCwrist circumference

*p* \< 0.05, statistically significant.

Discussion
==========

In summary, we found that WrC was positively associated with hypertension but only associated with DBP after adjustments for all confounders. The positive association of BP with WrC is not stronger than that observed in other generally used obesity indices. Consistently, the capacity of WrC in predicting hypertension was also found lower than BMI, WC and WHtR, which recognized as the most frequently used obesity indices.

WrC has attracted much attention in recent years, and became more and more popular in both clinical and research settings ([@ref-23]). Previous studies found a regulator of osteoblastic proliferation, differentiation and bone matrix apposition, named as insulin-like growth factor 1 (IGF-1), which showed 40% similarity in amino acid structure with insulin ([@ref-8]; [@ref-14]). Therefore, hyperinsulinemia was considered to be correlated with the bone growth ([@ref-7]), and WrC as a good surrogate assessing the cross-sectional area of bone then could be used to estimate the risks of insulin resistance, which was closely correlated with elevated BP. Meanwhile, some studies reported that individuals who are obese or overweight showed greater bone mass ([@ref-20]; [@ref-4]), which additionally implied that as a good measure of body frame and regional fat distribution ([@ref-25]; [@ref-22]; [@ref-16]; [@ref-35]), WrC could be used as an obesity index. Based on above knowledge and the strong positive association of obesity with CVD risk, several studies focusing on the associations of WrC with elevated BP as well as other metabolic abnormalities emerged ([@ref-13]; [@ref-23]; [@ref-10]; [@ref-21]), while no finding from Chinese populations was published. For example, Kelishadi et al. found that WrC was positively associated with BP and the metabolic syndrome, and inversely associated with HDL-C among 3,843 children and adolescents living in Iran ([@ref-13]). A cohort study (the mean follow-up of 8.8 years) from Iran suggested the positive associations of WrC with both metabolic syndrome (hazard ratio was 1.32 in male, and 1.40 in female) and diabetes (hazard ratio was 1.17 in male, and 1.31 in female) ([@ref-10]). Another 10-year-follow-up study from 3,642 asymptomatic Iran female participants (≥30 years old) showed that after adjustment for other conventional risk factors, WrC was still positively associated with hypertension (hazard ratio: 1.15; 95%CI \[1.06--1.25\]) ([@ref-21]). In contrast with previous findings, our study firstly showed that WrC is positive associated with hypertension after adjusting for confounding factors among northeastern Chinese population, particularly in male. The findings were in line with previous reports ([@ref-13]; [@ref-23]; [@ref-4]; [@ref-10]; [@ref-21]; [@ref-2]).

Additionally, the advantages of WrC measurements compared to other anthropometric obesity indices are continually emphasized. In contrast to WC, WrC was independent of respiration and stomach fullness ([@ref-24]; [@ref-28]). Also, no special assessment tools are required for WrC measurement, which led it easier to apply in health examination ([@ref-10]). However, no studies have compared the strengths of associations of WrC with metabolic abnormalities to other anthropometric obesity indices, using the standardized coefficients of each index. If the association of WrC was no stronger than other indices, it means that WrC do not need be measured additionally, and consumptions of the human power and the training for examiners can be saved. According to our current results, the positive association of WrC and hypertension is not stronger than the other traditional obesity indices. Firstly, [Table 2](#table-2){ref-type="table"} indicated us that WrC is only positive associated with DBP and the increase of DBP per SD of WrC is smallest compared to other obesity indices. Secondly, [Table 3](#table-3){ref-type="table"} showed that the OR values of WrC and hypertension was also revealed to be smallest among the six obesity indices. Additionally, the AUC values comparison in [Table 4](#table-4){ref-type="table"} further demonstrated that the capacity of WrC in predicting hypertension is statistically lower than BMI. All of these findings consistently implied that the WrC did not show better performance compared to the other traditional obesity indices with regard to the association with hypertension. On the contrary, the three conventional obesity indices, BMI, WC and WHtR, showed more strongly association with hypertension, with BMI as the strongest one. And thus, it should be more recommended in detecting the risk of hypertension in our specific population.

Cautions should be paid when interpreting our findings. Firstly, as a cross-sectional study, the causality between obesity indices and hypertension cannot be proven well, longitudinal following-up study should be made further to verify the current results. Secondly, only local residents were recruited from a single area in this study. Therefore, conclusions from this study may be different in other populations with various life-styles. Thirdly, several life-style factors correlated with hypertension, such as dietary intakes and physical activity were not considered in our study. Hypertension is a multifactorial and multigenic disease and then further studies focusing on associations of hypertension with both genetic factors and life-style factors should be continued. One of strengths in our study was that we randomly selected a community-based sample with a broad age range, which increases the generalizability of our results to general Chinese population. Secondly, we included not only WrC, but also other generally used anthropometric obesity indices into analyses, and compared strengths of associations with hypertension. Such systematic comparisons have not been reported previously, especially in northeastern Chinese population. We supposed that the current findings might provide a reference in selecting the appropriate anthropometric obesity indices to estimate the risk of hypertension.

Conclusions
===========

In the current study, we showed that WrC was associated with hypertension among Chinese northeastern populations, especially in adult males. However, the association was not stronger than other generally used obesity indices, particularly BMI. Our study suggested that WrC, as a novel anthropometric obesity index, to some extent can be used as a surrogate to estimate the risk of hypertension, while the application value was limited. In contrast, other commonly used obesity indices showed much more well performances in detecting hypertension risk. Thus, additional measurement of WrC is not recommended at least with regard to the issue of hypertension in this specific population.
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